skip to Main Content
Despite Pushback from DOJ, GOP Wants More Medical Marijuana Research

Some Utah residents are working overtime to get medical marijuana on the state’s ballot next year. They seem to have just gotten a surprising new Republican ally in their effort – Senator Orrin Hatch.

The state’s senior senator – an octogenarian who is third in line for the presidency – publicly broke ranks with Attorney General Jeff Sessions, GOP leaders and many of his Mormon constituents when he endorsed medicinal marijuana last week. When I caught up with him on an elevator on the Capitol grounds, surrounded by his ever-present security detail, I asked what brought about his evolution on the issue.

“There’s no transformation. I’ve always been for any decent medicine,” Hatch replied without hesitation. “I know that medical marijuana can do some things that other medicines can’t. I’m for alleviating pain and helping people with illness.”

Hatch is among a frustrated set of the nation’s policy makers who are up in arms over Washington Post report that Sessions’ Justice Department is blocking the Drug Enforcement Agency (DEA) from approving about two dozen proposals for experts to research the effects of marijuana. Not to legalize weed. Not to sell it. Not even to smoke it. Merely to study it – just as is allowed with deadly and highly addictive opioids, booze and even cigarettes – to find out if 38 states and the District of Columbia have made grave mistakes by allowing marijuana to be used either medicinally or recreationally, or whether those states are actually on to something. [Read more at Rolling Stone]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Hawaii Senate Kills ‘De Facto’ Weed Legalization

A bill to increase the amount of marijuana a person can possess before facing stiff criminal penalties failed 15-9 in the Hawaii Senate on Monday. It was the second defeat…

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

More Categories

Back To Top
×Close search
Search